All News

Kim writes about moving past a diagnosis and taking action.

Breast cancer and melanoma survivors shares thoughts to fight cancer fatigue from a book by Christiane Northrup, M.D.

There are many misconceptions about genetic testing in cancer, but the SGO crafted a new toolkit to help patients and providers navigate the field.

The FDA approved a Darzalex (daratumumab) triplet for the treatment of relapsed myeloma.

While Opdivo is currently the only immunotherapy agent approved for Hodgkin lymphoma, immunotherapy strategies are beginning to emerge in other indications in the field.

Linda T. Vahdat, M.D. discusses the findings of a recent phase 2 trial that may lead to the approval of a targeted therapy for triple-negative breast cancer.

Through music, Christian Hoff shares his message of hope for patients and survivors of cancer.

Long-term data from the phase 3 EF-14 study showed that Optune plus temozolomide had a survival benefit compared to temozolomide alone.

I was diagnosed in October and began chemotherapy at the beginning of November. The traditional month of food and family was one that I had always looked forward to.

Patients with breast cancer who had higher levels of vitamin D in their blood at diagnosis tended to have better outcomes, according to a recent study.

A brief interaction at the gym gives this metastatic breast cancer patient a reason to reflect on the hope we must nurture.

People from around the country, including actress and 16-year cancer survivor Fran Drescher , came to CURE's GBM Heroes event, honoring those who made an impact in the world of glioblastoma multiforme.

A promising treatment option is on the horizon for some patients with glioblastoma multiforme (GBM), says Martin van den Bent, M.D., Ph.D.

Everett Vokes, M.D. discusses what the future of immunotherapy might mean for patients with head and neck cancer.

Join us on Nov. 22 during the #CureConnect tweet chat to discuss facing the holidays with a cancer diagnosis.

Three recently-discovered molecular subtypes may help in crafting a more personalized treatment plan for men with prostate cancer.

Does PSA screening lead to an overtreatment of prostate cancer? Clayton S. Lau, M.D., discusses the topic.

We face loss everyday, and that's amplified this time of year--but there are things you can do to help.

Stress and depression can alter ovarian cancer tumors, often leading to poorer outcomes.

Cabometyx was proved to be superior to Sutent, reducing rates of disease progression or death for patients with metastatic RCC, according to a recent trial.

Thanks to recent clinical trials and FDA approvals, the treatment paradigm for multiple myeloma continues to shift.

PD-L1 expression should be used to determine frontline non-small cell lung cancer (NSCLC) treatment, says Matthew D. Hellmann, M.D.

Women who were vaccinated against HPV do not need to be screened for cervical cancer as often, according to a recent study.

Take back control in the midst of an uncontrolled situation.

Routine checkups can rattle us with technology and subconscious fears that tiptoe to the surface, even five years out. Perhaps going alone to important screenings is not the best idea. Taking a friend if you do not have a partner, even if you can do it all alone, is never a bad idea.

The future of multiple myeloma treatment may be in immunotherapy combinations, according to Eric L. Smith, M.D., Ph.D.